Diabetes Medicines

On completion of this activity, you should be able to:

  1. Identify which patients with type 2 diabetes might benefit from having their medicines reviewed.
  2. Determine which patients with type 2 diabetes could benefit from having a SGLT2 Inhibitor or a GLP-1A added to their medicine regimen, as per PBS eligibility criteria.
  3. Outline a GP management plan for patients with diabetes using a patient centred and multi-disciplinary approach.

ACRRM Activity No: 34676 - RACGP Activity No: 995928

Accredited_CPD
CPD_F


Accredited CPD Hours for GPs


This activity is available until May 29th 2025

  • Educational Activity - 2 hours
  • Reviewing Performance - 2.5 hours
  • Measuring Outcomes - 2.5 hours


A mini-audit framework for GPs


To claim accredited CPD hours please complete the following steps:

1. Complete the educational activity (minimum requirement)

2. Review your performance

Find up to five of your patients with a diagnosis of type 2 diabetes and CVD or CKD.

For each patient, review their record for their most recent HbAIC, prescribed diabetes medicines, and Medicines Review (see data collection template below).

Actions you could consider from the results of your mini-audit:

  • If there is a diagnosis of heart failure or CKD, consider prescribing an SGLT2-inhibitor for management of these conditions.
  • If the patient is not currently at their HbA1C target, review their prescribed medicines and consider escalation of therapy. Consider their comorbidities and the potential benefit of SGLT2-i or GLP1-A.
  • If there has been no medicines review (MBS items 900, 903, 245 and 249) within the past 12 months, consider referring for an HMR or RMMR.

Note: to be eligible to claim 2.5 hours of Measuring Outcomes you must review a minimum of five patients.

3. Measure the Outcomes

  • Keep a record of the five patients you identified and document any changes to management that were made (keep this record securely within your practice).


4. Claim your CPD hours

  • Complete the CPD response form to log your hours.
  • You will be asked to provide responses to the following questions to provide evidence that you have competed the activity:
    • Evidence required for claiming Educational Activity hours:
      • Review the HMR report in the case scenario. Which of these recommendations (if any) would you incorporate into a medication management plan? What do you consider the highest priority for Ben's medication management? Is anything missing that you think is important?



  • A certificate confirming your participation and the number of CPD hours awarded will be provided within 30 days.


CPD_kNLm51I.original
^Please note, to claim MO hours you must review a total of five patients and measure the outcomes relative to this practice review. If less than 5 patients have been reviewed, you will only be able to claim partial hours for the EA and RP parts of this activity. If you intend to claim MO hours, it is recommended that you wait until all three required activities have been completed to submit your claim. Any claim for MO hours made separately to claiming the prerequisite EA and RP hours must be made within 30 days of the initial submission. -

Participating in this MAIA topic on medicines and the kidneys is voluntary. It provides you with the opportunity to receive accredited RACGP or ACRRM hours for educational activities, reviewing performance and measuring outcomes. By participating in this topic, you agree to complete our response form which is required as evidence for your continuing professional development hours.


Data collected will be used to inform improvements to MAIA and could also be used in external publications and presentations. Individual responses will remain confidential, and no individuals will be identified in publications or presentations. Data will be securely stored in deidentified format at the University of South Australia. Identified data will be used for the sole purpose of CPD recording only.

Accredited CPD Hours for Pharmacists


Pharmacists can claim CPD points through the PSA, a member of the MAIA consortium.

The following resources and activities are available:

  • Recorded webinar
  • Pharmacist Quick Reference Guide
  • Pharmacist Case Series: Supporting patients with persistent pain
PSA_CPD_APC

On completion of this activity, you should be able to:

  1. Identify which patients with type 2 diabetes might benefit from having their medicines reviewed.
  2. Determine which patients with type 2 diabetes could benefit from having a SGLT2 Inhibitor or a GLP-1A added to their medicine regimen, as per PBS eligibility criteria.
  3. Outline a GP management plan for patients with diabetes using a patient centred and multi-disciplinary approach.